Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma-Reference-Cited by-同舟云学术

Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma

Published:2023-01-02 Issue:4 Volume:110 Page:407-413
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Shamriz Oded¹²^ORCID,Parnasa Elchanan³,Rubin Limor¹,Talmon Aviv¹,Ribak Yaarit¹,Lebel Eyal⁴,Vainstein Vladimir⁴,Aumann Shlomzion⁴,Saban Revital⁴,Gatt Moshe E.⁴,Tal Yuval¹

Affiliation:

1. Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine Hebrew University of Jerusalem Israel

2. The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel‐Canada, Faculty of Medicine Hebrew University of Jerusalem Israel

3. Division of Medicine, Hadassah Medical Center, Faculty of Medicine Hebrew University of Jerusalem Israel

4. Department of Hematology, Hadassah Medical Center, Faculty of Medicine Hebrew University of Jerusalem Israel

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13918

Reference18 articles.

1. Mechanism of action of lenalidomide in hematological malignancies

2. Practical Management of Lenalidomide-Related Rash

3. Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

4. The novel mechanism of lenalidomide activity

5. Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Desensitization Update: Key Concepts and Mechanisms;Current Treatment Options in Allergy;2023-12-27

2. Tailored to patient 7 to 10 day lenalidomide desensitization protocol;Journal of Investigational Allergology and Clinical Immunology;2023-06-01